Security key
31572Q881
KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB)
CUSIP: 31572Q881
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 3
- Total 13F value
- $20
- Share change
- +3
- SEC-reported price per share
- $6.67
- Number of holders
- 1
- Value change
- +$20
- Number of buys
- 1
- Shares outstanding
- 4,048,583
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
1
Top holders
1
KYNB full security history
Ownership snapshot
Full 13F holder table
KYNTRA BIO, INC. SEC filings
KYNTRA BIO, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31572Q881
Recent filing periods:
Ownership snapshot
Top reported holders of KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
3/15
Latest evidence
06 Sep 2026
13F
13D/G
3/4/5
Lead comparable stake: 9.9%
12 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 9.9%.
3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 3
ARMISTICE CAPITAL, LLC
9.9%
PRIMECAP MANAGEMENT CO/CA/
4.6%
VANGUARD GROUP INC
4.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
9.9%
Reported 13D/G
· 30 Jun 2026
|
$3,020,000
400,000 shares
|
— | 30 Jun 2026 |
| PRIMECAP MANAGEMENT CO/CA/ |
13D/G
|
4.6%
Reported 13D/G
· 31 Dec 2024
|
$1,523,323
4,616,130 shares
|
$0 | 31 Dec 2024 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
4.4%
Reported 13D/G
· 30 Jun 2025
|
$916,888
178,040 shares
|
$0 | 30 Jun 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$1,207,623
159,950 shares
|
— | 30 Jun 2026 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$795,000
105,585 shares
|
— | 30 Jun 2026 |
| Rory B. Riggs |
3/4/5
Director
|
—
mixed-class rows
|
$761,112
1,009,263 shares
mixed-class rows
|
— | 26 May 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
3
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
26
Q3 2026 holders
1
Holder diff
-25
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend